Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings

Vaccine

Volumn 34, Issue 14, 2016, Pages 1672-1679

  Feng, Shuo ^a   Cowling, Benjamin J ^a   Sullivan, Sheena G ^b,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Case control study; Influenza; Public health; Vaccination; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; HOSPITAL PATIENT; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; OUTPATIENT; PRIORITY JOURNAL; INFLUENZA, HUMAN; PREVALENCE; STATISTICS AND NUMERICAL DATA; VACCINATION;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INPATIENTS; OUTPATIENTS; PREVALENCE; VACCINATION;

EID: 84975687795     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.02.039     Document Type: Article

References (28)

1. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel E.F., Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000, 342:225-231.
2. Emukule G.O., Khagayi S., McMorrow M.L., Ochola R., Otieno N., Widdowson M.-A., et al. The burden of influenza and RSV among inpatients and outpatients in rural western Kenya, 2009-2012. PLOS ONE 2014, 9:e105543.
3. Sullivan S.G., Feng S., Cowling B.J. Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review. Expert Rev Vaccines 2014, 13:1571-1591.
4. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31:2165-2168.
5. Foppa I.M., Haber M., Ferdinands J.M., Shay D.K. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31:3104-3109.
6. Carrat F., Vergu E., Ferguson N.M., Lemaitre M., Cauchemez S., Leach S., et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008, 167:775-785.
7. Gruver A., Hudson L., Sempowski G. Immunosenescence of ageing. J Pathol 2007, 211:144-156.
8. Guide CI, Ottawa Centers for Disease Control and Prevention Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence 1993, vol. 42:1-18. MMWR. 6th ed.
9. Turner N., Pierse N., Bissielo A., Huang Q., Radke S., Baker M., et al. Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013. Euro Surveill 2014, 19:20884.
10. Martínez-Baz I., Navascués A., Pozo F., Chamorro J., Albeniz E., Casado I., et al. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus. Hum Vaccines Immunother 2015, 11:1626-1633.
11. Carpenter J., Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med 2000, 19:1141-1164.
12. Cheng A.C., Kotsimbos T., Kelly H.A., Irving L.B., Bowler S.D., Brown S.G., et al. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study. Vaccine 2011, 29:7320-7325.
13. Levy A., Sullivan S.G., Tempone S.S., Wong K.L., Regan A.K., Dowse G.K., et al. Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012. Vaccine 2014, 32:6312-6318.
14. Kwong J.C., Campitelli M.A., Gubbay J.B., Peci A., Winter A.-L., Olsha R., et al. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis 2013, 10.1093/cid/cit404.
15. Skowronski D.M., Janjua N.Z., De Serres G., Winter A.-L., Dickinson J.A., Gardy J.L., et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation. Canada 2010-2011 season. Clin Infect Dis 2012, 10.1093/cid/cis431.
16. Puig-Barberà J., García-de-Lomas J., Díez-Domingo J., Arnedo-Pena A., Ruiz-García M., Limón-Ramírez R., et al. Influenza vaccine effectiveness in preventing influenza A (H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A (H3N2) predominant influenza season, Valencia, Spain. PLOS ONE 2014, 9:e112294.
17. Jiménez-Jorge S., de Mateo S., Delgado-Sanz C., Pozo F., Casas I., Garcia-Cenoz M., et al. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination. BMC Infect Dis 2013, 13:441.
18. Talbot H.K., Zhu Y., Chen Q., Williams J.V., Thompson M.G., Griffin M.R. Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season. Clin Infect Dis 2013, 10.1093/cid/cit124.
19. Ohmit S.E., Thompson M.G., Petrie J.G., Thaker S.N., Jackson M.L., Belongia E.A., et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014, 58:319-327.
20. Fielding J.E., Grant K.A., Garcia K., Kelly H.A. Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010. Emerg Infect Dis 2011, 17:1181.
21. Cheng A.C., Brown S.G., Waterer G.W., Holmes M., Senenayake S., Friedman N.D., et al. Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2012: the Influenza Complications Alert Network (FluCAN). Commun Dis Intell 2013, 213. 17.3.
22. Sullivan S.G., Chilver M., Higgins G., Cheng A.C., Stocks N.P. Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network. Med J Aust 2014, 201:109-111.
23. Pierse N., Kelly H., Thompson M.G., Bissielo A., Radke S., Huang Q.S., et al. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014. Vaccine 2015, 34:503-509.
24. Cheng A.C., Holmes M., Irving L.B., Brown S., Waterer G.W., Korman T.M., et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-2011 seasons: a test-negative observational study. PLOS ONE 2013, 8:e68760.
25. Lau L.L., Ip D.K., Nishiura H., Fang V.J., Chan K-H., Peiris J.M., et al. Heterogeneity in viral shedding among individuals with medically attended influenza A virus infection. J Infect Dis 2013, 207:1281-1285.
26. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987, 9:1-30.
27. Ng S., Ni M.Y., Fang V.J., Ip D., Chan K-H., Leung G.M., et al. Characteristics of vaccine failures in a randomized placebo-controlled trial of inactivated influenza vaccine in children. Pediatr Infect Dis J 2014, 33:e63-e66.
28. Arriola C.S., Anderson E.J., Baumbach J., Bennett N., Bohm S., Hill M., et al. Does influenza vaccination modify influenza severity? Data on older adults hospitalized with influenza during the 2012-2013 season in the United States. J Infect Dis 2015, 10.1093/infdis/jiv200.